295 related articles for article (PubMed ID: 28403145)
41. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM
J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622
[TBL] [Abstract][Full Text] [Related]
42. Development of treatment strategies to combat Ebola and Marburg viruses.
Paragas J; Geisbert TW
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Phenol-Substituted Diphyllin Derivatives as Selective Antagonists for Ebola Virus Entry.
Plescia CB; Lindstrom AR; Quintero MV; Keiser P; Anantpadma M; Davey R; Stahelin RV; Davisson VJ
ACS Infect Dis; 2022 May; 8(5):942-957. PubMed ID: 35357134
[TBL] [Abstract][Full Text] [Related]
44. A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus.
Flint M; Chatterjee P; Lin DL; McMullan LK; Shrivastava-Ranjan P; Bergeron É; Lo MK; Welch SR; Nichol ST; Tai AW; Spiropoulou CF
Nat Commun; 2019 Jan; 10(1):285. PubMed ID: 30655525
[TBL] [Abstract][Full Text] [Related]
45. Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection.
Ren J; Zhao Y; Fry EE; Stuart DI
J Med Chem; 2018 Feb; 61(3):724-733. PubMed ID: 29272110
[TBL] [Abstract][Full Text] [Related]
46. Toremifene interacts with and destabilizes the Ebola virus glycoprotein.
Zhao Y; Ren J; Harlos K; Jones DM; Zeltina A; Bowden TA; Padilla-Parra S; Fry EE; Stuart DI
Nature; 2016 Jul; 535(7610):169-172. PubMed ID: 27362232
[TBL] [Abstract][Full Text] [Related]
47. Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.
Radoshitzky SR; Warfield KL; Chi X; Dong L; Kota K; Bradfute SB; Gearhart JD; Retterer C; Kranzusch PJ; Misasi JN; Hogenbirk MA; Wahl-Jensen V; Volchkov VE; Cunningham JM; Jahrling PB; Aman MJ; Bavari S; Farzan M; Kuhn JH
J Virol; 2011 Sep; 85(17):8502-13. PubMed ID: 21697477
[TBL] [Abstract][Full Text] [Related]
48. Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells.
Johnson JC; Martinez O; Honko AN; Hensley LE; Olinger GG; Basler CF
Antiviral Res; 2014 Jul; 107():102-9. PubMed ID: 24815087
[TBL] [Abstract][Full Text] [Related]
49. Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.
Wang LL; Estrada L; Wiggins J; Anantpadma M; Patten JJ; Davey RA; Xiang SH
Antiviral Res; 2022 Oct; 206():105399. PubMed ID: 36007601
[TBL] [Abstract][Full Text] [Related]
50. PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling.
Cai X; Xu Y; Cheung AK; Tomlinson RC; Alcázar-Román A; Murphy L; Billich A; Zhang B; Feng Y; Klumpp M; Rondeau JM; Fazal AN; Wilson CJ; Myer V; Joberty G; Bouwmeester T; Labow MA; Finan PM; Porter JA; Ploegh HL; Baird D; De Camilli P; Tallarico JA; Huang Q
Chem Biol; 2013 Jul; 20(7):912-21. PubMed ID: 23890009
[TBL] [Abstract][Full Text] [Related]
51. [Study of gonadal hormone drugs in blocking filovirus entry of cells in vitro].
Wang LL; Chen Q; Zhou LN; Guo Y
Yao Xue Xue Bao; 2015 Dec; 50(12):1545-50. PubMed ID: 27169275
[TBL] [Abstract][Full Text] [Related]
52. The Methanolic Extract of
Kuo YT; Liu CH; Corona A; Fanunza E; Tramontano E; Lin LT
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578374
[TBL] [Abstract][Full Text] [Related]
53. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
[TBL] [Abstract][Full Text] [Related]
54. Filovirus entry: a novelty in the viral fusion world.
Hunt CL; Lennemann NJ; Maury W
Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
[TBL] [Abstract][Full Text] [Related]
55. AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus.
Kondratowicz AS; Hunt CL; Davey RA; Cherry S; Maury WJ
J Virol; 2013 Jan; 87(2):746-55. PubMed ID: 23115293
[TBL] [Abstract][Full Text] [Related]
56. Structural and Energetic Basis for Differential Binding of Ebola and Marburg Virus Glycoproteins to a Bat-Derived Niemann-Pick C1 Protein.
Igarashi M; Hirokawa T; Takada A
J Infect Dis; 2023 Nov; 228(Suppl 7):S479-S487. PubMed ID: 37119290
[TBL] [Abstract][Full Text] [Related]
57. Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor.
Cui Q; Du R; Anantpadma M; Schafer A; Hou L; Tian J; Davey RA; Cheng H; Rong L
Viruses; 2018 Mar; 10(4):. PubMed ID: 29584652
[TBL] [Abstract][Full Text] [Related]
58. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
[TBL] [Abstract][Full Text] [Related]
60. The Inability of Marburg Virus to Cause Disease in Ferrets Is Not Solely Linked to the Virus Glycoprotein.
Schiffman Z; Garnett L; Tran KN; Cao W; He S; Emeterio K; Tierney K; Azaransky K; Strong JE; Banadyga L
J Infect Dis; 2023 Nov; 228(Suppl 7):S594-S603. PubMed ID: 37288605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
